Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs NKGen Biotech, Inc. (NKGN)

BioLineRx Ltd. and NKGen Biotech, Inc. are both Biotechnology companies. BioLineRx Ltd. and NKGen Biotech, Inc. are of similar size ($8.8M and $8.8M). NKGen Biotech, Inc. has the higher net margin (0.00% vs −502.1%) and the higher return on invested capital (0.00% vs −74.3%). Across the 12 metrics below, NKGen Biotech, Inc. leads on 7 and BioLineRx Ltd. on 5.

Valuation

Metric BLRX NKGN Biotechnology median
P/E n/m n/m 10.60
P/S 5.52 n/m 9.40
P/B 0.46 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.94 n/m 9.02
Earnings yield (92.56%) (10,600.00%) (32.88%)
Free cash flow yield (141.04%) (4,296.38%) (23.13%)

Profitability

Metric BLRX NKGN Biotechnology median
Gross margin 80.03% — 68.51%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) 44.70% (51.96%)
Return on assets (18.21%) (146.49%) (46.06%)
Return on invested capital (74.28%) 0.00% 0.00%

Growth

Metric BLRX NKGN Biotechnology median
Revenue growth (TTM) (91.93%) — 6.76%
EPS growth (last fiscal year) 93.72% 71.38% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BLRX NKGN Biotechnology median
Debt to equity 0.40 (0.59) 0.00
Current ratio 1.20 0.05 4.97
Net debt to EBITDA 1.22 (1.69) 1.01

Dividend

Metric BLRX NKGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLRX NKGN Biotechnology median
Market cap 8.80m 8.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack